Latest Financial Performance News

ANZ is executing a $248 million on-market share buyback via UBS to neutralise shares issued under its Dividend Reinvestment Plan for the 2026 interim dividend, with a 12-day pricing period ending 1 June 2026.

Gratifii Limited has secured $10 million in new capital to acquire Simplicity Loyalty and invest strategically in Marketplacer, aiming to broaden its loyalty and rewards platform across Australia and New Zealand.

AVITA Medical reported a 4% revenue increase in Q1 2026 with a narrowed net loss, underpinned by a new BARDA contract and promising Cohealyx clinical data. Leadership changes and regulatory approvals support a confident outlook.

oOh!media posts solid early 2026 revenue growth and launches a $12 million annual savings program, while exiting retail media and navigating takeover bids.

Worley unveils a medium-term growth strategy through FY30 focused on expanding full project delivery, investing $70 million in AI, and leveraging strategic partnerships amid near-term geopolitical challenges.

Synlait Milk announces CEO Richard Wyeth's resignation effective end of June, with Acting CEO Leon Fung appointed immediately to steer through ongoing operational challenges.

Vista Group International is set to roll out its Digital Enablement platform across 88 Cineworld cinemas in the UK during 2026, building on last year’s deployment at 25 Picturehouse sites.

ReadCloud announces CEO Andrew Skelton’s departure after three years of operational overhaul and financial turnaround, appointing CFO Luke Murphy as interim CEO amid strong growth momentum.

Paladin Energy Ltd (ASX:PDN) swung to a quarterly profit with US$8.4 million gross profit and bolstered its balance sheet through a A$400 million equity raise, positioning itself for expansion in uranium production and development.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.

Magontec Limited reported a robust first quarter in 2026, with gross profit surging 63% and metals sales volumes up 58%, driven by margin improvements and strategic expansion in electronic anodes and magnesium alloys.